elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37669978-58926C99-AF61-4274-9E9F-4247B10D192B
Q37669978-58926C99-AF61-4274-9E9F-4247B10D192B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37669978-58926C99-AF61-4274-9E9F-4247B10D192B
A review of drugs in development for the personalized treatment of head and neck squamous cell carcinoma.
P2860
Q37669978-58926C99-AF61-4274-9E9F-4247B10D192B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37669978-58926C99-AF61-4274-9E9F-4247B10D192B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
64f596dadc388e7ff12e593613d27a36c0b64951
P2860
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.